AEON Biopharma Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
8
- Stock Symbol
-
AEON
- Investments
-
1
- Share Price
-
$0.15
- (As of Friday Closing)
AEON Biopharma General Information
Description
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Contact Information
Website
www.aeonbiopharma.comCorporate Office
- 130 Vantis Drive
- Suite 170
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 130 Vantis Drive
- Suite 170
- Aliso Viejo, CA 92656
- United States
AEON Biopharma Stock Performance
As of 13-Nov-2026, AEON Biopharma’s stock price is $0.15. Its current market cap is $10.9M with 71.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.15 | $0.16 | $0.13 - $1.45 | $10.9M | 71.5M | 7.59M | -$4.39 |
AEON Biopharma Financials Summary
As of 30-Jun-2026, AEON Biopharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 15,305 | 25,644 | 37,549 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (54,545) | (39,144) | 42,102 | (52,488) |
| Net Income | (54,623) | (39,222) | 42,005 | (52,556) |
| Total Assets | 5,910 | 5,560 | 3,142 | 10,778 |
| Total Debt | 2,775 | 35,745 | 12,955 | 131,791 |
AEON Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AEON Biopharma Comparisons
Industry
Financing
Details
AEON Biopharma Competitors (7)
One of AEON Biopharma’s 7 competitors is Ipsen, a Formerly PE-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ipsen | Formerly PE-Backed | Paris, France | ||||
| Vanda Pharmaceuticals | Formerly VC-backed | Washington, DC | ||||
| Contineum Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Tris Pharma | Private Debt Financed | Monmouth Junction, NJ | ||||
| Nektar Therapeutics | Formerly VC-backed | San Francisco, CA |
AEON Biopharma Patents
AEON Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023384143-A1 | Optimization of botulinum toxin treatment of migraine and other headache disorders | Pending | 22-Nov-2022 | ||
| WO-2024112924-A2 | Optimization of botulinum toxin treatment of migraine and other headache disorders | Inactive | 22-Nov-2022 | ||
| WO-2024112924-A3 | Optimization of botulinum toxin treatment of migraine and other headache disorders | Inactive | 22-Nov-2022 | ||
| AU-2023375349-A1 | Compositions for use in treating headache disorders | Pending | 07-Nov-2022 | ||
| US-20260355285-A1 | Compositions for use in treating headache disorders | Pending | 07-Nov-2022 | A61K38/26 |
AEON Biopharma Signals
AEON Biopharma Acquisitions (1)
AEON Biopharma’s most recent deal was a Merger/Acquisition with Priveterra Acquisition for . The deal was made on 21-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Priveterra Acquisition | 21-Jul-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
AEON Biopharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
AEON Biopharma FAQs
-
When was AEON Biopharma founded?
AEON Biopharma was founded in 2012.
-
Where is AEON Biopharma headquartered?
AEON Biopharma is headquartered in Aliso Viejo, CA.
-
What is the size of AEON Biopharma?
AEON Biopharma has 8 total employees.
-
What industry is AEON Biopharma in?
AEON Biopharma’s primary industry is Drug Discovery.
-
Is AEON Biopharma a private or public company?
AEON Biopharma is a Public company.
-
What is AEON Biopharma’s stock symbol?
The ticker symbol for AEON Biopharma is AEON.
-
What is the current stock price of AEON Biopharma?
As of 13-Nov-2026 the stock price of AEON Biopharma is $0.15.
-
What is the current market cap of AEON Biopharma?
The current market capitalization of AEON Biopharma is $10.9M.
-
Who are AEON Biopharma’s competitors?
Ipsen, Vanda Pharmaceuticals, Contineum Therapeutics, Tris Pharma, and Nektar Therapeutics are some of the 7 competitors of AEON Biopharma.
-
What is AEON Biopharma’s annual earnings per share (EPS)?
AEON Biopharma’s EPS for 12 months was -$4.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process